Market Place
Sourcing Support
Vividion Therapeutics Appoints Frank Poschen to Board of Directors
08 Oct 2024 //
BUSINESSWIRE
Vividion Therapeutics To Expand Global R&D Centre And HQ In San Diego
24 Jul 2024 //
PHARMABIZ
Vividion Therapeutics to Expand with New Global Research and Development Center
22 Jul 2024 //
BUSINESSWIRE
Tavros Achieves Two Milestones In Vividion Collaboration
14 May 2024 //
GLOBENEWSWIRE
Tavros achieves milestones in collaboration with Bayer’s Vividion
14 May 2024 //
BIOSPACE
Vividion, Roche Publish Landmark Paper on Covalent WRN Inhibitor
25 Apr 2024 //
BUSINESSWIRE
Bayer, Vividion Highlight Oncology Portfolio at AACR 2024
03 Apr 2024 //
PRESS RELEASE
Vividion starts Phase I trial in advanced solid with oral STAT3 inhibitor
06 Feb 2024 //
PRESS RELEASE
Vividion Therapeutics starts Phase I clinical trial with oral STAT3 inhibitor
06 Feb 2024 //
BUSINESSWIRE
Vividion Recognized as a San Diego area ‘Top Workplaces 2023’ Award Winner
21 Nov 2023 //
BUSINESSWIRE
Vividion Therapeutics initiates Phase I clinical trial with KEAP1 activator in advanced solid tumors
18 Sep 2023 //
PRESS RELEASE
Vividion Therapeutics Names Shawn Rose as Chief Development Officer
07 Sep 2023 //
BUSINESSWIRE
Vividion Therapeutics Promotes Matt Patricelli to Chief Scientific Officer
23 Mar 2023 //
BUSINESSWIRE
Vividion 2.0? Ben Cravatt and Scripps team form a new chemoproteomics biotech
04 Jan 2023 //
ENDPTS
Bayer`s Vividion Bets up to $930M for Tavros Oncology Partnership
13 Oct 2022 //
BIOSPACE
An RA-backed startup `ATACs` a novel challenge
18 Nov 2021 //
ENDPTS
Bayer nabs star biotech Vividion with a $2B buyout and an ‘arms-length’ pact
06 Aug 2021 //
ENDPTS
Vividion Therapeutics Earns First Milestone Payment
26 Jun 2021 //
BUSINESSWIRE
Vividion Announces $135 Million Series C Financing to Fuel Broad
24 Feb 2021 //
BUSINESSWIRE
Jeff Hatfield assembles a syndicate with some A-list investors in the mix
24 Feb 2021 //
ENDPTS
Ex-Vividion chief Diego Miralles finds `dream team` at stealthy Flagship
12 Feb 2021 //
ENDPTS
Jeffrey Hatfield takes over from Diego Miralles as CEO of Vividion; Dragonfly
25 Nov 2020 //
ENDPTS
Vividion Brings in Proven Industry Leader Jeffrey Hatfield as CEO
23 Nov 2020 //
BUSINESSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.